Please login to the form below

Not currently logged in
Email:
Password:

Dr Robert Califf confirmed as new head of the FDA

US Senate votes in favour of his appointment to lead the regulator

Robert CaliffThe US Senate has confirmed Dr Robert Califf's appointment to be the new FDA commissioner, replacing Margaret Hamburg who resigned last March.

A cardiologist and medical researcher, Dr Califf joined the FDA in January 2015 as deputy commissioner for medical products and tobacco and was nominated for the commissioner role by President Barack Obama shortly after Hamburg announced her departure.

The FDA's acting commissioner of food and drugs Stephen Ostroff said: “Dr Califf has demonstrated a long and deep commitment to advancing the public health throughout his distinguished career as a physician, researcher and leader in the fields of science and medicine.

“He understands well the critical role that the FDA plays in responding to the changes in our society while protecting and promoting the health of the public.”

But Dr Califf faced a harder than expected confirmation hearing, which politicians used as an opportunity to quiz the FDA on its record on opioid painkillers.

Fatal overdoses from prescription opioid painkillers have quadrupled since the late 1990s, with some arguing the regulator had approved too many of the drugs, with too few safeguards on their use.

Prior to joining the FDA in January 2015 Dr Califf was vice chancellor of clinical and translational research at Duke University in North Carolina in the US. His previous roles at Duke include director of the Duke Translational Medicine Institute (DTMI) and professor of medicine in the Division of Cardiology. He was also founding director of the Duke Clinical Research Institute.

His time at the Institute, a contract research organisation, also brought criticism of Dr Califf from some quarters due the links it has with the pharmaceutical industry.

Article by
Dominic Tyer

25th February 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

Sharing our insights from the eyeforpharma, Barcelona 2016 patient track
A year on from the 'launch' of patient-centricity as a key theme at eyeforpharma and how have things progressed?...
An effective commercial model for cancer care
Patient-centric cancer care...
Blog_icon_understanding-the-adoption-ladder-in-closed-loop-marketing.png
Flexible content checklist – five questions to ask
To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning or developing core materials....

Infographics